Evidence map›Paper›PMID 25364642›Full record

ArticleBrain disorders & therapy2012

At the Fulcrum in Health and Disease: Cdk5 and the Balancing Acts of Neuronal Structure and Physiology.

Kristina A McLinden, Svetlana Trunova, Edward Giniger

Open access · greenAbstract read
In one paragraph

Article in Brain disorders & therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Three decades of Cdk5.Journal of biomedical science · 2021
    Review
  7. Article
  8. CDK5 Inhibition Abrogates TNBC Stem-Cell Property and Enhances Anti-PD-1 Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Article
  9. Cdk5-Dependent Phosphorylation of CaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  10. Article
  11. Multiple Layers ofInternational journal of molecular sciences · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.Developmental dynamics : an official publication of the American Association of Anatomists · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kristina A McLindenNational Institute of Neurological Disorders and Stroke, USA ; National Human Genome Research Institute, USA.
Svetlana TrunovaNational Institute of Neurological Disorders and Stroke, USA ; National Human Genome Research Institute, USA.
Edward GinigerNational Institute of Neurological Disorders and Stroke, USA ; National Human Genome Research Institute, USA.
National Institute of Neurological Disorders and Stroke · US

Funding

Roles of Cdk5 in neurodevelopment and neurodegenerationZIANS003106 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI GINIGER, EDWARD · 2009 to 2025
$17.0M
Intramural NIH HHS ZIA NS003106
6 · The paper itself

Abstract

Cdk5 has been implicated in a multitude of processes in neuronal development, cell biology and physiology. These influence many neurological disorders, but the very breadth of Cdk5 effects has made it difficult to synthesize a coherent picture of the part played by this protein in health and disease. In this review, we focus on the roles of Cdk5 in neuronal function, particularly synaptic homeostasis, plasticity, neurotransmission, subcellular organization, and trafficking. We then discuss how disruption of these Cdk5 activities may initiate or exacerbate neural disorders. A recurring theme will be the sensitivity of Cdk5 sequelae to the precise biological context under consideration.

Indexed as

Cdk5Cyclin-dependent kinaseDendrite developmentNeuronal structureSynapse

Identifiers

PMID25364642
PMCPMC4212508
OpenAlexW2106571070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.